The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Javed Butler from Stony Brook University: Is A Low Salt Diet Right for Heart Failure Patients?
For a chronic condition like heart failure there are many factors that can help decide the effectiveness of their care. A recent debate looked at whether low salt diet would help in that effort.
Douglas Zipes from Indiana School of Medicine: Challenges of Research When Hypotheses Not Met
Even the most seasoned medical research teams can find themselves not reaching the goals they set out for themselves in a study. Learning from those lessons can sometimes be more motivation to find answers down the road.
Jay Edelberg from Sanofi: Praluent Continues to Show Benefits Since Approval
At the 2015 meeting of the American College of Cardiology PCSK9 inhibitors like Praluent were moving closer to approval but were not there yet. Since then they have been approved and begun to be introduced to the public.
Vegan Diet: It's Powerful Medicine Kim Williams, MD, says in Q&A
The American College of Cardiology's outgoing President Kim A. Williams, MD, went vegan in 2003 and never looked back. He talks about the diet's power to heal and how being the ACC's first vegan leader played out.
Kevin Campbell from the University of North Carolina: Finding Best Ways to Engage on Social Media
How a doctor presents themselves on social media can determine how effective it is in getting their message across while also maintaining a safe barrier between them and their patients.
Hayes Dansky from Janssen Pharmaceuticals: Xarelto Continues to Show Positive Results in Practice
As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.
Frank W. Peacock IV from Baylor College of Medicine: Rivaroxaban Shows Benefits for Diabetics
As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.
Vagus Nerve Stimulation Shows Some Benefit in Heart Failure
An electronic device that stimulates the vagus nerve improved patients’ ability to walk farther without getting winded and was proven to be safe, but it did not affect rates of death or hospitalization, researchers found.
TAVR Device: from Non-Inferior to Superior in One Day
A newer version of a valve system used in transcatheter aortic valve replacement has proved superior to surgery in elderly patients. The study was released a day after a report on the older device showed it was as good as surgery.
Surprising Findings in Genetic Analysis of Familial Hypercholesterolemia Patients
A large genetic analysis showed that the incidence of a single genetic mutation in familial hypercholesterolemia patients is smaller than thought--but that those who do have the mutation face a far higher risk of heart disease.
ACC Opener: Turning off the Spigot in Heart Disease
There were hundreds of presentations on high-tech innovations and the latest drugs for heart disease. But unless cardiologists find better ways to prevent cardiovascular illness, deaths will keep rising, the ACC's Kim Williams, MD said in his welcome speech.
HOPE-3: Polypill Quest Stumbles with Statin-Antihypertensive Combo
Population health—the quest to improve the physical well-being of people around the world—is increasingly focused on prevention. But giving antihypertensives plus statins to people who do not have high blood pressure has risks.